🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
Evaluate mFOLFOX6 (5-Fluorouracil, Leucovorin and Oxaliplatin) chemotherapy...
Status
Active Not Recruiting
Location
University of Rochester
Start Date
2017-06-19
Trial ID
NCT03110926
Treatments Being Tested
This prospective study was designed to assess the outcomes (survival and fa...
Status
Unknown
Location
The Oregon Clinic
Start Date
2000-07
Trial ID
NCT00139633
Treatments Being Tested
The purpose of this study is to evaluate if the addition of GSK3359609 to p...
Status
Terminated
Location
GSK Investigational Site
Start Date
2020-08-12
Trial ID
NCT04428333
Treatments Being Tested
The purpose of this study is to explore the activity of ZD1839 added to con...
Status
Completed
Location
The University of Chicago Medical Center
Start Date
2003-01-27
Trial ID
NCT01185171
Treatments Being Tested
This is a first-in-human, open-label, non-randomized, three-part phase 1 tr...
Status
Recruiting
Location
HonorHealth Research Institute
Start Date
2018-10-08
Trial ID
NCT03715933
This phase III trial compares pembrolizumab with radiation therapy to pembr...
Status
Active Not Recruiting
Location
Moffitt Cancer Center-International Plaza
Start Date
2023-06-08
Trial ID
NCT05721755
A Phase 2 Study of evorpacept (ALX148) in Combination With pembrolizumab an...
Status
Active Not Recruiting
Location
Hoag Hospital
Start Date
2021-05-10
Trial ID
NCT04675333
Treatments Being Tested
This is a Phase 1/2, open label study. Phase 1 consists of 2 parts. Part 1 ...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2014-11-26
Trial ID
NCT02327078
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as docetaxel, cisplatin, fluoro...
Status
Completed
Location
Rebecca and John Moores UCSD Cancer Center
Start Date
2004-08
Trial ID
NCT00095875
Treatments Being Tested